Correlation between oxidation of low density lipoproteins and prostacyclin synthesis in cultured smooth muscle cells.
The effect of antioxidants on the oxidation of low density lipoproteins in relation to prostacyclin synthesis was investigated in the prescence of rabbit smooth muscle cells (SMC) and Fe-containing culture medium. The lipid peroxidation of low density lipoproteins (LDL) assayed as thiobarbituric acid reactive substances was increased from 0.5 to 1.4 nmol malondialdehyde/mL by the presence of smooth muscle cells. Two potent antioxidants, nordihydroguairetic acid (NDGA) and butylated hydroxytoluene (BHT), inhibited lipoprotein oxidation by IC50 values of 0.2 and 0.8 microM, respectively. Inhibition of lipoprotein oxidation was associated with an increased prostacyclin synthesis by the SMC, the effect being more pronounced with nordihydroguairetic acid than with butylated hydroxytoluene. The stable metabolite of the lipid hydroperoxide, 15-hydroxyeicosatetraenoic acid (15-HETE), formed in the 15-lipoxygenase pathway was measured following antioxidant treatment and found to be eliminated or greatly reduced by both antioxidants. The results presented show that lipid hydroperoxides, formed as a consequence of lipoprotein oxidation and promoted by the smooth muscle cells through a lipoxygenase reaction, may regulate prostacyclin synthase, a process which may be influenced by the addition of antioxidants.
Ek
B
B
Department of Cardiovascular Biochemistry, Hässle Cardiovascular Research Laboratories, Mölndal, Sweden.
Humble
L
L
D000818:Animals; D002084:Butylated Hydroxytoluene / Q000494:pharmacology; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000096:biosynthesis*; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism; D015227:Lipid Peroxidation; D008077:Lipoproteins, LDL / Q000378:metabolism*; D016859:Lipoxygenase Inhibitors; D008315:Malondialdehyde / Q000378:metabolism; D009637:Masoprocol / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D010084:Oxidation-Reduction; D011817:Rabbits; D013858:Thiobarbiturates / Q000378:metabolism
D006893:Hydroxyeicosatetraenoic Acids; D008077:Lipoproteins, LDL; D016859:Lipoxygenase Inhibitors; D013858:Thiobarbiturates; D002084:Butylated Hydroxytoluene; D008315:Malondialdehyde; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid; D009637:Masoprocol; D011464:Epoprostenol; C029684:thiobarbituric acid